Evidence map›Paper›PMID 20456945›Full record

ArticleEuropean journal of cancer (Oxford, England : 1990)2010

Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.

Deirdre P Cronin-Fenton, Liam J Murray, David C Whiteman, Chris Cardwell, Penelope M Webb, Susan J Jordan, Douglas A Corley, Linda Sharp, Jesper Lagergren, Barrett's Esophagus, Adenocarcinoma Consortium (BEACON) Investigators

Open access · greenAbstract read
In one paragraph

Article in European journal of cancer (Oxford, England : 1990), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 5 countries.

Deirdre P Cronin-FentonDepartment of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes 43-45, 8200 Aarhus N, Denmark. l.hol.1@erasmusmc.nl
Liam J Murray
David C Whiteman
Chris Cardwell
Penelope M Webb
Susan J Jordan
Douglas A Corley
Linda Sharp
Jesper Lagergren
Barrett's Esophagus, Adenocarcinoma Consortium (BEACON) Investigators
QIMR Berghofer Medical Research Institute · AUUniversity of Queensland · AUAarhus University Hospital · DKKaiser Permanente · USKarolinska Institutet · SENational Cancer Registry · IE

Funding

Epidemiology and Incidence of Barrett's EsophagusR01DK063616 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORLEY, DOUGLAS ALLEN · 2002 to 2010
$2.6M
Chief Scientist OfficeMedical Research CouncilNIDDK NIH HHS R01 DK063616NIDDK NIH HHS R01 DK63616
6 · The paper itself

Abstract

backgroundThe rapidly rising incidence and the striking male predominance are as yet unexplained features of oesophageal and gastric junction adenocarcinoma. Few and underpowered studies have examined the impact of female reproductive factors on risk of these adenocarcinomas in women. We therefore pooled data on women from four population-based case-control studies to examine the association of female reproductive and sex hormonal factors with oesophageal and gastric junction adenocarcinoma.

methodsData on women from case-control studies conducted in Ireland, the United Kingdom (UK), Australia and United States of America (USA) were pooled. Multivariable logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for a range of reproductive factors, adjusted for age, study and major risk factors for oesophageal and gastric junction adenocarcinoma.

resultsWe included 218 cases and 862 controls. Among parous women, a reduced risk of oesophageal and gastric junction adenocarcinoma was found after breastfeeding (OR=0.58, 95% CI=0.37-0.92) and the risk decreased with increased duration of breastfeeding (>12 months OR=0.42, 95% CI=0.23-0.77). The endogenous reproductive factors such as parity, menstruation, history of pregnancy and the exogenous factors such as use of oral contraceptives and of hormone replacement therapy were not statistically significantly associated with oesophageal and gastric junction adenocarcinoma.

conclusionOur findings suggest that breastfeeding is associated with a decreased risk of oesophageal and gastric junction adenocarcinoma. The potential mechanism of this association warrants further investigation.

Indexed as

Breast FeedingEsophagogastric JunctionAdenocarcinomaAdultAgedCase-Control StudiesEsophageal NeoplasmsFemaleGonadal Steroid HormonesHormone Replacement TherapyHumansMiddle AgedRisk FactorsGonadal Steroid Hormones

Identifiers

PMID20456945
PMCPMC5542412
OpenAlexW2142261509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.